(NASDAQ: ESTA) is a global medical company focused on improving patient safety and cosmetic outcomes in the cosmetic and reconstruction markets by designing, developing, manufacturing and marketing an innovative portfolio of silicone breast implants, under the Motiva Implants® brand, the heart of the MotivaImagine® platform.
Motiva Implants® are produced at our two manufacturing sites, in compliance with ISO13485: 2016, FDA 21 CFR 820 and the MDSAP program. They are currently sold in more than 80 countries through exclusive distributors or the company's sales force. In addition to Motiva Implants®, the Establishment Labs product and technologies portfolio of products and technologies includes the Divina® 3D Simulation System, Puregraft and MotivaImagine® Centers.
Establishment Labs has alliances with Universities in Costa Rica, the United States, the United Kingdom, Austria, Italy and Australia.